Is Moderna Stock a Buy?

Is Moderna Stock a Buy?

Moderna (NASDAQ: MRNA) made some big waves in late 2018, with its initial public offering (IPO) becoming the biggest ever for a biotech. The wave grew even larger this year as Moderna quickly emerged as a leader in the race to develop a coronavirus vaccine. The most obvious risk is that its pipeline candidates could stumble in clinical testing.